Contact

Our portfolio

Quantib

Quantib focuses on improving patient care by bringing AI radiology solutions into clinical practice. Started in 2012 as a spin-out from Erasmus MC, University Medical Center Rotterdam, Quantib now has AI partnerships with the three largest academic hospitals in the Netherlands and with hospitals and private providers internationally.

  • Institute: Amsterdam UMC
Industry: AI, Digital Health, Imaging
  • Founding year: 2011
Visit website

Want to get in contact about Quantib?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Figlinq
Enabling secure AI-assisted data management, analysis, visualization, sharing, and FAIR publishing.
Pepper Therapeutics
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Nano Hybrids
Advancing nanotechnology with sustainable, solvent-free nanoparticle synthesis.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Figlinq
Enabling secure AI-assisted data management, analysis, visualization, sharing, and FAIR publishing.
Pepper Therapeutics
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Explore full AAV portfolio
Contact